These findings indicated that the anti-PGF antibody attenuated hyperoxia-induced aberrant pulmonary vascular growth, thereby demonstrating the potential therapeutic role of anti-PGF antibodies in BPD. Here, PGF is linked to bronchopulmonary dysplasia.